Meglumine

Meglumine is a derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. It is used as an excipient for drug formulations and for preparing salts. The meglumine or combined meglumine-sodium salts of triiodinated benzoic acid derivatives, diatrizoic and iothalamic acid, are commonly used as intravascular ionic contrast media for radiographic visualization of blood vessels and the urinary tract. Meglumine salts of iodoxamate and iodipamide are also used for intravenous cholangiography. Meglumine shows protective effects in Type II Diabetes. It significantly improves glycemic control and lowers levels of plasma and liver triglycerides in a mice model of type 2 Diabetes.

https://pubchem.ncbi.nlm.nih.gov/compound/8567

Small volumes of Meglumine biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS8400476 is a biochemical targeting Meglumine.